Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-07-23 00:27 CEST (UTC+2h)

Counterintuitive? [Design Issues]

posted by nobody - 2018-04-03 11:16  - Posting: # 18634
Views: 1,696

Hy!

Found this Easter egg:

https://link.springer.com/article/10.1007/s11095-018-2387-4?

...only read the abstract, but the findings and Conclusion are not really intuitive to me (still in mild post-prandial coma, I must admit). Why should the most appropriate AUC metric depend on the release rate of the Test product relative to reference?

Any ideas how to wrap my head around this?

Kindest regards, nobody

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,547 posts in 3,941 threads, 1,190 registered users;
online 11 (0 registered, 11 guests [including 9 identified bots]).

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed